Fiona Socolow
Memorial Sloan Kettering Cancer Center
3 papers found
Refreshing results…
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
UploadRegorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
UploadMissing publications? Search for publications with a matching author name.